Keywords: AvWS; acquired von Willebrand syndrome; BTT; bridge to transplant; CF; continuous flow; DT; destination therapy; FDA; Food and Drug Administration; GI; gastrointestinal; HF; heart failure; HM; HeartMate; HTx; heart transplant; INR; international normalize
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AVWS; acquired von Willebrand syndrome; ELISA; enzyme linked immunosorbent assay; EQA; external quality assessment; FVIII:C; FVIII coagulant; GPIb; glycoprotein Ib; HMW; high molecular weight (VWF); LIA; latex-particle immuno-assay; VWD; von Willebrand di
Keywords: AVWS; acquired von Willebrand syndrome; ELISA; enzyme linked immunosorbent assay; EQA; external quality assessment; FVIII:C; FVIII coagulant; GPIb; glycoprotein Ib; HMW; high molecular weight (VWF); LIA; latex-immuno-assay; VWD; von Willebrand disease; VW
Full Length ArticleTranscatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - Incidence and relevance of clinical and subclinical VWF dysfunction in patients unde
Keywords: ACT; activated clotting time; AVWS; acquired von Willebrand syndrome; LES; Logistic EuroScore; (HMW-) VWF; (High molecular weight)- von Willebrand factor; PVL; paravalvular leakage; SAVR; surgical aortic valve replacement; STS-PROM; Society of Thoracic Su
Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo
Keywords: AVWS; acquired Von Willebrand syndrome; BCS; Behring Coagulation System; FVIII:C; coagulation factor VIII; GPIb; platelet receptor glycoprotein Ib; HMW; high molecular weight; U/ml; units per milliliter; VWD; Von Willebrand disease; VWF; Von Willebrand fa
A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand Syndrome
Keywords: ELISA; Enzyme-linked immunosorbent assay; AVWS; acquired von Willebrand Syndrome; FVIII:C; factor VIII coagulant activity; VWF; von Willebrand Factor; VWF:RCo; von Willebrand Factor Ristocetin Cofactor; VWF:Ag; von Willebrand Factor antigen; VWF:CB; von W
Laboratory identification of factor inhibitors: an update
Keywords: APTT; Bethesda assay; Factor inhibitors; lupus inhibitor; mixing tests; replacement therapy; APTT; activated partial thromboplastin time; aVWS; acquired von Willebrand syndrome; DIC; disseminated intravascular coagulation; dRVVT; dilute Russell's viper
Acquired von Willebrand Syndrome in Continuous-Flow Ventricular Assist Device Recipients
Keywords: aPTT; activated partial thromboplastin time; AVWS; acquired von Willebrand syndrome; CBC; collagen-binding capacity; CF; continuous flow; GI; gastrointestinal; HMW; high molecular weight; INR; international normalized ratio; LVAD; left ventricular assist
Use of Intravenous Immunoglobulin in Patients With Acquired von Willebrand Syndrome
Keywords: acquired von Willebrand syndrome; von Willebrand factor; factor VIII/von Willebrand factor activities; autoantibodies; intravenous immunoglobulin; Ag; antigen; AVWS; acquired von Willebrand syndrome; FVIII/VWF; factor VIII and von Willebrand factor comple
bcr/abl-Negative, Classic Myeloproliferative Disorders: Diagnosis and Treatment
Keywords: AHSCT; allogeneic hematopoietic stem cell transplantation; AvWS; acquired von Willebrand syndrome; BM; bone marrow; CML; chronic myeloid leukemia; EMH; extramedullary hematopoiesis; ET; essential thrombocythemia; Hct; hematocrit; JAK; Janus kinase; MDS; m